Study in Patients With Knee Osteoarthritis Treated by Embolization Using NBGM200
Recruiting · NCT06930677 · Interventional (participants receive a specific treatment) · Lead sponsor: Next Biomedical Co., Ltd.
View the official record on ClinicalTrials.gov →Interventions studied
embolization therapy
What this trial is about
Study in patients with knee osteoarthritis treated by embolization using NBGM200
Who can take part
Age range
50 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Osteoarthritis proven by MR-imaging
Exclusion criteria
- Current local infection
- Life expectancy less than 6 months
Where it is running
3 locations listed.
- University Hospital Ghent - Ghent, Belgium
- Uz Leuven - Leuven, Belgium
- Elisabeth-Tweesteden Hospital - Tilburg, Netherlands